GENE ONLINE|News &
Opinion
Blog

Antibody
Singapore’s A*STAR Invests in HoneyBear, Accelerating ARC Cancer Drug Development
2025-03-28
Sanofi and AstraZeneca’s RSV Antibody Drug Gets FDA Approval, Adding New Weapon for Preventing Infant Infections
2023-07-18
Jounce Sells Anti-CCR8 Antibody to Gilead, Forgoing $645 Million In Milestones
2022-12-28
AstraZeneca’s Treatment for COVID-19 Wins European Approval
2022-09-20
Antibody Treatment for Multiple Varieties of CoronaVirus
2022-08-16
Gilead Spends $405 Million In Cash to Acquire MiroBio
2022-08-05
Takeda Throws $1 Million at F-star to Develop Bispecific Antibody For Novel Cancer Therapies
2022-07-21
Asahi Kasei Medical Ups CDMO Business in the US with Bionova Buy
2022-04-21
Moderna Shares Promising Preliminary Bivalent COVID-19 Booster Results
2022-04-20
How the IHMED Reproductive Center Improves Infertility Outcomes by Targeting Immune Response
2022-04-19Partner
EMA Begins Review of BeiGene, Novartis’s PD-1 Antibody for Esophageal and Lung Cancer
2022-04-13
EUA of Monoclonal Antibodies Revoked: Are Oral COVID Drugs the Only Hope?
2022-04-06
Roche’s Phase III Trial of ES-SCLC Immunotherapy Fails to Extend Progression-Free Survival
2022-04-05
Sanofi Bets $2.5 billion on Adagene to Make Antibodies Safer
2022-03-03
EMA Accepts Application for AstraZeneca’s Anti-RSV Antibody Nirsevimab.
2022-02-21
1 2 3 6
LATEST
AACR Annual Meeting 2025: Cancer Research Innovations, NIH Funding Advocacy, and AI-Driven Advances
2025-04-28
Senti Biosciences to Showcase New Cell & GeneTherapy Data at AACR Annual Meeting 2025
2025-04-27
World Vaccine Congress Washington 2025 Recap: Urgent Calls for Trust, Tech, and Global Access
2025-04-25
Astellas’ Transformation Journey: From Merger to Global Player, Betting on the Edge of Innovation and Risk?
2025-04-25
Roche Announces Massive 50 Billion Dollar Investment in the United States
2025-04-25
Steminent Stands Ready to Showcase Novel MSC-based Therapy for Spinocerebellar Ataxia at Global Stage
2025-04-24
Arkansas Medicaid Work Requirements Led to Coverage Loss for a Significant Number of Recipients
2025-04-24
EVENT
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
Scroll to Top